Related references
Note: Only part of the references are listed.Antisense-induced Myostatin Exon Skipping Leads to Muscle Hypertrophy in Mice Following Octa-guanidine Morpholino Oligomer Treatment
Jagjeet K. Kang et al.
MOLECULAR THERAPY (2011)
beta(2)-Agonists and Physical Performance A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Babette M. Pluim et al.
SPORTS MEDICINE (2011)
Mass spectrometric detection of siRNA in plasma samples for doping control purposes
Maxie Kohler et al.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY (2010)
Designing highly active siRNAs for therapeutic applications
S. Patrick Walton et al.
FEBS JOURNAL (2010)
Sequencing of Single and Double Stranded RNA Oligonucleotides by Acid Hydrolysis and MALDI Mass Spectrometry
Ute Bahr et al.
ANALYTICAL CHEMISTRY (2009)
RNA Interference: From Basic Research to Therapeutic Applications
Jens Kurreck
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2009)
Asthma in elite athletes: how do we manage asthma-like symptoms and asthma in elite athletes?
Clinical Respiratory Journal (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study. (vol 8, pg 918, 2009)
M. Kinali et al.
LANCET NEUROLOGY (2009)
Biological Barriers to Therapy with Antisense and siRNA Oligonucleotides
R. Juliano et al.
MOLECULAR PHARMACEUTICS (2009)
The Effect of Chemical Modification and Nanoparticle Formulation on Stability and Biodistribution of siRNA in Mice
Shan Gao et al.
MOLECULAR THERAPY (2009)
A large-scale chemical modification screen identifies design rules to generate siRNAs with high activity, high stability and low toxicity
Jesper B. Bramsen et al.
NUCLEIC ACIDS RESEARCH (2009)
Androgen abuse in the community
Bodo C. Melnik
CURRENT OPINION IN ENDOCRINOLOGY DIABETES AND OBESITY (2009)
Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
Maria Kinali et al.
LANCET NEUROLOGY (2009)
Antisense therapy against CCR3 and the common beta chain attenuates allergen-induced eosinophilic responses
Gail M. Gauvreau et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
Collision-induced Dissociation of Intact Duplex and Single-Stranded siRNA Anions
Teng-yi Huang et al.
ANALYTICAL CHEMISTRY (2008)
Improved serum stability and biophysical properties of siRNAs following chemical modifications
Ik Sang Cho et al.
BIOTECHNOLOGY LETTERS (2008)
Metabolite identification of small interfering RNA duplex by high-resolution accurate mass spectrometry
Yan Zou et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2008)
Myostatin antisense RNA-mediated muscle growth in normal and cancer cachexia mice
C-M Liu et al.
GENE THERAPY (2008)
Mass spectrometric determination of insulins and their degradation products in sports drug testing
Mario Thevis et al.
MASS SPECTROMETRY REVIEWS (2008)
Local dystrophin restoration with antisense oligonucleotide PRO051
Judith C. van Deutekom et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Chemical modification: the key to clinical application of RNA interference?
David R. Corey
JOURNAL OF CLINICAL INVESTIGATION (2007)
Strategies for bioanalysis of an oligonucleotide class macromolecule from rat plasma using liquid chromatography-tandem mass spectrometry
Guodong Zhang et al.
ANALYTICAL CHEMISTRY (2007)
A mutation in the myostatin gene increases muscle mass and enhances racing performance in heterozygote dogs
Dana S. Mosher et al.
PLOS GENETICS (2007)
Specificity, duplex degradation and subcellular localization of antagomirs
Jan Krutzfeldt et al.
NUCLEIC ACIDS RESEARCH (2007)
Cross-species pharmacokinetic comparison from mouse to man of a second-generation antisense oligonucleotide, ISIS 301012, targeting human apolipoprotein B-100
Rosie Z. Yu et al.
DRUG METABOLISM AND DISPOSITION (2007)
Targeted delivery systems of small interfering RNA by systemic administration
Shigeru Kawakami et al.
DRUG METABOLISM AND PHARMACOKINETICS (2007)
Characterization of the secondary structure and stability of an RNA aptamer that binds vascular endothelial growth factor
Melanie Bozza et al.
BIOCHEMISTRY (2006)
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting
C Esau et al.
CELL METABOLISM (2006)
Silencing of microRNAs in vivo with 'antagomirs'
J Krützfeldt et al.
NATURE (2005)
Liquid chromatography/electrospray mass spectrometric analysis of metabolites from an inhibitory RNA duplex
M Beverly et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2005)
Rational siRNA design for RNA interference
A Reynolds et al.
NATURE BIOTECHNOLOGY (2004)
Pegaptanib for neovascular age-related macular degeneration
ES Gragoudas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs
J Soutschek et al.
NATURE (2004)
Brief report -: Myostatin mutation associated with gross muscle hypertrophy in a child
M Schuelke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Antisense technologies - Improvement through novel chemical modifications
J Kurreck
EUROPEAN JOURNAL OF BIOCHEMISTRY (2003)
Analysis of nucleic acids by on-line liquid chromatography-mass spectrometry
CG Huber et al.
MASS SPECTROMETRY REVIEWS (2001)
A new method for the postsynthetic generation of abasic sites in oligomeric DNA
IG Shishkina et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2000)
Share Paper
